Physician profile
Andres Smith
NPI 1548270200
$20,477.69
in general payments reported to CMS, 2019-2025
18 companies · $184 in 2025
The $184 reported for 2025 was more than what 81% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,728 · 2020: $131 · 2021: $6,064 · 2022: $3,866 · 2023: $907 · 2024: $597 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17,439.67 | 2019-2025 | Watchman Access System, Watchman Flx |
| Inari Medical, INC. | $791.87 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $424.58 | 2021-2023 | Biomonitor |
| Abbott Laboratories | $419.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $363.53 | 2019-2022 | |
| Edwards Lifesciences Corporation | $194.87 | 2023 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $154.37 | 2024 | |
| Novo Nordisk INC | $146.41 | 2022-2024 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $138.33 | 2021 | |
| Pfizer INC. | $132.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $129.25 | 2019 | |
| Lilly USA, LLC | $44.66 | 2020-2023 | Mounjaro |
| Radius Health, INC. | $19.24 | 2020 | |
| Viatris Specialty LLC | $18.97 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $16.90 | 2023 | M-M-R II, Varivax, Vaxneuvance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $16.04 | 2025 | Doc Band |
| Kiniksa Pharmaceuticals, Ltd. | $13.77 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.